|
⚲
|
| Keyboard |
| Morabito Christopher
✚
|
|
|---|---|
| CIK # | 0001859284 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001859284] | |
| 4 | [0001859284] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Catabasis Pharmaceuticals Inc | |
| Morabito Christopher | |
| Fulcrum Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 262,500 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 80,000 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2025-03-21 | Grant | 262,500 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Common Stock
|
2024-04-01 | Sell | 10,000 | $13.59 | 135,900 |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2024-04-01 | Option exercise | 10,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Common Stock
|
2024-04-01 | Option exercise | 10,000 | $3.87 | 38,700 |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2024-02-08 | Grant | 175,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Common Stock
|
2024-01-29 | Sell | 9,200 | $11.15 | 102,580 |
|
Catabasis Pharmaceuticals Inc ATXS
Common Stock
|
2024-01-29 | Option exercise | 9,200 | $3.87 | 35,604 |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2024-01-29 | Option exercise | 9,200 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Common Stock
|
2024-01-26 | Option exercise | 800 | $3.87 | 3,096 |
|
Catabasis Pharmaceuticals Inc ATXS
Common Stock
|
2024-01-26 | Sell | 800 | $11.02 | 8,816 |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2024-01-26 | Option exercise | 800 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2023-06-02 | Grant | 90,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (right to buy) · derivative
|
2022-08-01 | Grant | 100,000 | $0.00 | |
|
Fulcrum Therapeutics Inc FULC
Stock Option (right to buy) · derivative
|
2022-01-19 | Grant | 59,744 | $0.00 | |
|
Fulcrum Therapeutics Inc FULC
Common Stock
|
2021-06-28 | Buy | 1,100 | $9.16 | 10,076 |
|
Fulcrum Therapeutics Inc FULC
Stock Option (right to buy) · derivative
|
2021-05-10 | Grant | 163,000 | $0.00 |